Globalization of clinical trials in oncology: a worldwide quantitative analysis
Despite the growth in oncology clinical trials, significant disparities in trial distribution and access remain, especially in LMICs. Continued investments in research infrastructure and adherence to ethical standards are crucial to ensure that clinical research benefits are equitably distributed, particularly in regions with the greatest need for advanced cancer therapies.
Authors
- I. Ray-Coquard
- J. Henry
- J.-Y. Blay
- Sylvain Besle (ORCID: https://orcid.org/0000-0002-4906-502X)
- Floriane Izarn (ORCID: https://orcid.org/0000-0002-4116-8243)
- Benoît Allignet (ORCID: https://orcid.org/0000-0001-7275-0773)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- École Normale Supérieure de Lyon (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre Léon Bérard (FR)
- Health Services and Performance Research Laboratory (FR)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Chimie et Biologie des Membranes et des Nanoobjects (FR)
- Triangle : Action, Discours, Pensée politique et économique (FR)
- Research on healthcare performance (FR)
Publication Details
- Journal
- ESMO Open
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1016/j.esmoop.2024.104086
- Citations
- 14
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 7.60
Funders
- Institut National de la Santé et de la Recherche Médicale